BGLC BioNexus Gene Lab Corp
Nasdaq · SEC CIK 1737523 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $0 0 sales by 0 insiders
- Filings on record
- 5 since 2026-08-14, latest 2026-08-14 17:20
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Low Jook Yuen | Dir | — | — |
| Tan Lee Su-Leng | CEO, Dir, 10% | — | — |
| Bin Abdul Hamid Muhammad Azrul | Dir | — | — |
| Chong Set Fui | CFO | — | — |
| Yap Chee Keong | Dir | — | — |
Transactions 5
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-14 17:20 | 2026-08-13 | BGLC | Tan Lee Su-Leng | CEO, Dir, 10% | A - Grant | — | +338.7K | 338.7K | New | — | |
| 2026-08-14 17:19 | 2026-08-13 | BGLC | Yap Chee Keong | Dir | A - Grant | — | +32.3K | 32.3K | New | — | |
| 2026-08-14 17:18 | 2026-08-13 | BGLC | Bin Abdul Hamid Muhammad Azrul | Dir | A - Grant | — | +32.3K | 32.3K | New | — | |
| 2026-08-14 17:17 | 2026-08-13 | BGLC | Chong Set Fui | CFO | A - Grant | — | +96.8K | 96.8K | New | — | |
| 2026-08-14 17:14 | 2026-08-13 | BGLC | Low Jook Yuen | Dir | A - Grant | — | +16.1K | 17.4K | +1,279% | — |
Purchase Sale Sale after option exercise All abbreviations